ARTICLES BY THIS AUTHOR
- 7/31/2010
Editorial: Sunny Signs
It’s summertime, and given the scrutiny and strain the profession has been under these past several months, I suspect all of you are ready for a reprieve from the limelight. - 7/31/2010
Guide to OTC Health Management: Skin Tags
Skin tags are composed of an overgrowth of normal epithelial cells, which enclose a dermal connective tissue stalk made up of loose, edematous collagen fibres, blood cells and sometimes fat cells. - 7/31/2010
Research Highlights: Ivermectin for resistant head lice
Resistance of lice to topical insecticides is widely documented and often results in treatment failure. Here are some alternatives. - 7/31/2010
CSHP 2015: A progress report
A series of toolkits to help pharmacists achieve three of the top 2015 objectives is also in the works. - 7/31/2010
Editorial: The worker is worthy of his wage
The service you provide has real value—it’s not wrong to make a good living caring for people. - 7/31/2010
Drug News: Actemra, BuTrans, Onsolis, Victoza
Actemra: first IL-6 receptor inhibitor for RA; BuTrans: first once-weekly transdermal opioid; Onsolis: opioid buccal film for breakthrough cancer pain; Victoza: first GLP-1 analogue for type 2 diabetes - 7/31/2010
Adverse Reactions: Pharmacogenetic screening to prevent ADRs
A recent review highlighted the emerging role of pharmacogenetic screening for the prevention of severe cutaneous adverse drug reactions (ADRs) such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and hypersensitivity syndrome reaction (HSR).